WASHINGTONPOST (Daniel Wu) - A melanoma vaccine was hailed as a breakthrough. Which cancers are next?
Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.
Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.
Tempus CEO Eric Lefkofsky discusses the company's artificial intelligence-driven precision medicine partnership with Merck on ‘The Claman Countdown.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #tempus #ericlefkofsky #lefkofsky #merck #ai #artificialintelligence #healthcare #precisionmedicine #medicine #medicalresearch #technology #clinicaldata #patientcare #healthtech
Two researchers who study the debilitating sleep disorder have won a prestigious Lasker Award. Their research in animals laid the groundwork for a new drug that addresses the condition’s root cause.
Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.
A new drug shows promise in reducing the symptoms of COPD, one of the top 10 leading cause of death in the U.S., according to the CDC.
Moderna co-founder and board chairman Noubar Afeyan discusses the phase three success of the Moderna-Merck cancer vaccine trial and explains how the vaccine targets unique mutations to help prevent melanoma recurrence on ‘The Claman Countdown.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #theclamancountdown #moderna #merck #cancer #vaccine #health #medicine #medical #melanoma #science #research #trial #biotech #technology #treatment #breakthrough #healthcare #innovation
Revolution Medicines CEO Dr. Mark Goldsmith discusses the clinical trial results from Rasonque on ‘FBN’s Wall Street.’ #fox #media #breakingnews #us #usa #new #news #breaking #foxbusiness #fbnswallstreet #markgoldsmith #goldsmith #revolutionmedicines #rasonque #cancer #cancertreatment #clinicaltrial #biotech #biotechnology #healthcare #medicalresearch #medicine #pharmaceuticals #investing
A new study suggests psilocybin could protect nerves from chemotherapy damage, potentially helping patients avoid a debilitating side effect.
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
It is too hard for medical researchers to launch clinical trials.